Navigation Links
DuPont Names Nicholas Fanandakis as Group Vice President - DuPont Applied BioSciences
Date:1/14/2008

Company Accelerating Efforts to Commercialize Bio-Based Technologies to

Meet Growing Global Demand

WILMINGTON, Del., Jan. 14 /PRNewswire-FirstCall/ -- DuPont (NYSE: DD) has named Nicholas C. Fanandakis group vice president - DuPont Applied BioSciences. In this newly created position, Fanandakis will lead the company's accelerated efforts to commercialize a range of bio-based products and technologies to meet growing global demand.

DuPont Applied BioSciences includes the following businesses: BioFuels, BioMaterials, BioSpecialties and BioMedical.

"Renewable energy, renewably sourced materials and other bio-based technologies are in high demand by the industries we serve," said Executive Vice President and Chief Innovation Officer Thomas M. Connelly, Jr. "DuPont is in a strong leadership position with a robust pipeline of product candidates, many of which are the result of the focused application of our scientific capabilities beginning more than a decade ago. With three decades of business leadership experience, Nick will lead our accelerated charge to deliver these products to the global marketplace."

Fanandakis, 51, currently vice president of planning, previously served four years as vice president and general manager of DuPont Chemical Solutions Enterprise. He has held a range of business leadership roles since joining the company in 1979.

William J. Harvey, 57, currently vice president - Corporate Operations, will succeed Fanandakis as vice president of planning.

DuPont is a science-based products and services company. Founded in 1802, DuPont puts science to work by creating sustainable solutions essential to a better, safer, healthier life for people everywhere. Operating in more than 70 countries, DuPont offers a wide range of innovative products and services for markets including agriculture and food; building and construction; communications; and transportation.

(Bios and photos of Nicholas Fanandakis and William Harvey are available at http://www2.dupont.com/Our_Company/en_US/executives/index.html )


'/>"/>
SOURCE DuPont
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. DuPont Leaders Brief Investors on Agriculture Businesses
2. DuPont, Genencor International and Tate & Lyle Honored for Groundbreaking Work in Developing Bio-PDO(TM)
3. DuPont and Plantic Technologies Announce Starch-Based Bio Materials Collaboration
4. DuPont Named Among Top Biotechnology Employers by Science Magazine
5. Biotechnology Needed to Help Meet Growing Global Needs for Food, Feed, Fuel and Materials, DuPont Chairman & CEO Says at World Food Prize
6. DuPont Joint Venture with Chinese Biotech Firm Strengthens Gene Discovery Research Efforts
7. DuPont Congratulates Growers Planting Pioneer(R) Brand Sorghum Hybrids in Winning Majority of National Categories in Yield Contest
8. KGI Names Kerry Howell Vice President for Advancement
9. Vical Names Andrew de Guttadauro Vice President, Corporate Development
10. IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development
11. Magellan Biosciences Names Steven E. Diamond, PhD, Chief Scientific Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... ROCKVILLE, Md. , Feb. 21, 2017 Synthetic ... therapeutics designed to preserve the microbiome to protect and restore the ... for the year ended December 31, 2016 on Thursday, March 2, ... 4:30 p.m. EST. The dial-in information for the call is as ... ...
(Date:2/21/2017)... ... February 21, 2017 , ... ... build connected digital health applications, announced a partnership with Redox, a leader in ... connect to many clinical systems while keeping data secure in the cloud. , ...
(Date:2/21/2017)... (PRWEB) , ... February 21, 2017 , ... ... and biotech research and development (R&D), today announced the establishment of Genedata Limited ... Managing Director Kevin Teburi, a recognized expert in life science informatics. Creating the ...
(Date:2/21/2017)... , ... February 21, 2017 , ... The medical potential ... their use, in multiple areas of medicine, due to their differentiating characteristics. Stem cells ... they have the ability to be induced to become tissue or organic-specific cells with ...
Breaking Biology Technology:
(Date:2/3/2017)...  Texas Biomedical Research Institute announced that its Board of ... as the Institute,s new President and CEO. Dr. Schlesinger will ... He is currently the Chair of the Department of Microbial ... Interface Biology at Ohio State University. "We are ... CEO of Texas Biomed," said Dr. James O. Rubin ...
(Date:2/2/2017)...  Central to its deep commitment to honor ... Japan Prize Foundation today announced the laureates of ... envelope in their respective fields of Life Sciences ... being recognized with the 2017 Japan Prize for ... to the advancement of science and technology, but ...
(Date:1/26/2017)...  Crossmatch, a leading provider of security and identity ... combatting fraud, waste and abuse in assistance operations around ... on Disaster Relief conference in Panama City ... and foreign assistance organizations throughout Latin America ... a largely unacknowledged problem in the foreign assistance and ...
Breaking Biology News(10 mins):